Evolutionary conflicts between viruses and restriction factors shape immunity

Nature Reviews Immunology

Volumn 12, Issue 10, 2012, Pages 687-695

  Duggal, Nisha K ^a,b   Emerman, Michael ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; RESTRICTION FACTOR; RESTRICTION FACTOR APOBEC3; RESTRICTION FACTOR FV1; RESTRICTION FACTOR IFITM1; RESTRICTION FACTOR IFITM2; RESTRICTION FACTOR IFITM3; RESTRICTION FACTOR MX1; RESTRICTION FACTOR MXA; RESTRICTION FACTOR PKR; RESTRICTION FACTOR SAMHD1; RESTRICTION FACTOR TRIM CYP; RESTRICTION FACTOR ZAP; TETHERIN; TRIPARTITE MOTIF PROTEIN 5; UNCLASSIFIED DRUG; VIPERIN;

GENE DUPLICATION; GENE MUTATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HUMAN; INFECTION SENSITIVITY; INNATE IMMUNITY; MOLECULAR EVOLUTION; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SURVIVAL; VERTEBRATE; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS VIRULENCE;

ANIMALS; BIOLOGICAL EVOLUTION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; VIRUSES;

EID: 84866740475     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3295     Document Type: Review

References (104)

1. Pincus, T., Rowe, W. P. & Lilly, F. A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus. J. Exp. Med. 133, 1234-1241 (1971).
2. Takaoka, A. & Yanai, H. Interferon signalling network in innate defence. Cell. Microbiol. 8, 907-922 (2006).
3. Wilkins, C. & Gale, M. Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 22, 41-47 (2010).
4. Refsland, E. W. et al. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 38, 4274-4284 (2010).
5. Koning, F. A. et al. Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J. Virol. 83, 9474-9485 (2009).
6. Stetson, D. B. Connections between antiviral defense and autoimmunity. Curr. Opin. Immunol. 21, 244-250 (2009).
7. Laguette, N. et al. SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657 (2011).
8. Hrecka, K. et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658-661 (2011).
9. Johnson, W. E. & Sawyer, S. L. Molecular evolution of the antiretroviral TRIM5 gene. Immunogenetics 61, 163-176 (2009).
10. Le Tortorec, A., Willey, S. & Neil, S. J. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction. Viruses 3, 520-540 (2011).
11. Okeoma, C. M., Lovsin, N., Peterlin, B. M. & Ross, S. R. APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 445, 927-930 (2007).
12. Okeoma, C. M., Petersen, J. & Ross, S. R. Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection. J. Virol. 83, 3029-3038 (2009).
13. Haller, O., Acklin, M. & Staeheli, P. Influenza virus resistance of wild mice: wild-type and mutant Mx alleles occur at comparable frequencies. J. Interferon Res. 7, 647-656 (1987).
14. Tan, K. S. et al. In vivo and in vitro studies on the antiviral activities of viperin against influenza H1N1 virus infection. J. Gen. Virol. 93, 1269-1277 (2012).
15. Swiecki, M., Wang, Y., Gilfillan, S., Lenschow, D. J. & Colonna, M. Cutting edge: paradoxical roles of BST2/tetherin in promoting type I IFN response and viral infection. J. Immunol. 188, 2488-2492 (2012).
16. Barrett, B. S. et al. A single nucleotide polymorphism in tetherin promotes retrovirus restriction in vivo. PLoS Pathog. 8, e1002596 (2012).
17. Liberatore, R. A. & Bieniasz, P. D. Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo. Proc. Natl Acad. Sci. USA 108, 18097-18101 (2011).
18. Everitt, A. R. et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519-523 (2012).
19. Tareen, S. U. & Emerman, M. Human Trim5α has additional activities that are uncoupled from retroviral capsid recognition. Virology 409, 113-120 (2011).
20. Pertel, T. et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472, 361-365 (2011).
21. Rice, G. I. et al. Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune response. Nature Genet. 41, 829-832 (2009).
22. Malim, M. H. & Emerman, M. HIV-1 accessory proteins - ensuring viral survival in a hostile environment. Cell Host Microbe 3, 388-398 (2008).
23. Hatziioannou, T. et al. Generation of simian-tropic HIV-1 by restriction factor evasion. Science 314, 95 (2006).
24. Kamada, K. et al. Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells. Proc. Natl Acad. Sci. USA 103, 16959-16964 (2006).
25. Yu, X. et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060 (2003).
26. Mehle, A., Goncalves, J., Santa-Marta, M., McPike, M. & Gabuzda, D. Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 18, 2861-2866 (2004).
27. Kueck, T. & Neil, S. J. A cytoplasmic tail determinant in HIV-1 Vpu mediates targeting of tetherin for endosomal degradation and counteracts interferon-induced restriction. PLoS Pathog. 8, e1002609 (2012).
28. Elde, N. C. & Malik, H. S. The evolutionary conundrum of pathogen mimicry. Nature Rev. Microbiol. 7, 787-797 (2009).
29. Van Valen, L. A new evolutionary law. Evol. Theory 1, 1-30 (1973).
30. Han, G.-Z. & Worobey, M. An endogenous foamy-like viral element in the coelacanth genome. PLoS Pathog. 8, e1002790 (2012).
31. Nielsen, R. & Yang, Z. Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148, 929-936 (1998).
32. Grossman, S. R. et al. A composite of multiple signals distinguishes causal variants in regions of positive selection. Science 327, 883-886 (2010).
33. Kelley, J. L. & Swanson, W. J. Positive selection in the human genome: from genome scans to biological significance. Annu. Rev. Genom. Hum. Genet. 9, 143-160 (2008).
34. Hanada, K., Suzuki, Y. & Gojobori, T. A large variation in the rates of synonymous substitution for RNA viruses and its relationship to a diversity of viral infection and transmission modes. Mol. Biol. Evol. 21, 1074-1080 (2004).
35. Jenkins, G. M., Rambaut, A., Pybus, O. G. & Holmes, E. C. Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J. Mol. Evol. 54, 156-165 (2002).
36. Shackelton, L. A., Parrish, C. R., Truyen, U. & Holmes, E. C. High rate of viral evolution associated with the emergence of carnivore parvovirus. Proc. Natl Acad. Sci. USA 102, 379-384 (2005).
37. Shackelton, L. A. & Holmes, E. C. Phylogenetic evidence for the rapid evolution of human B19 erythrovirus. J. Virol. 80, 3666-3669 (2006).
38. Holmes, E. C. Error thresholds and the constraints to RNA virus evolution. Trends Microbiol. 11, 543-546 (2003).
39. Sharp, P. M., Bailes, E., Stevenson, M., Emerman, M. & Hahn, B. H. Gene acquisition in HIV and SIV. Nature 383, 586-587 (1996).
40. Hughes, A. L. & Yeager, M. Natural selection at major histocompatibility complex loci of vertebrates. Annu. Rev. Genet. 32, 415-435 (1998).
41. Verrelli, B. C. et al. Evidence for balancing selection from nucleotide sequence analyses of human G6PD. Am. J. Hum. Genet. 71, 1112-1128 (2002).
42. Newman, R. M. et al. Balancing selection and the evolution of functional polymorphism in Old World monkey TRIM5α. Proc. Natl Acad. Sci. USA 103, 19134-19139 (2006).
43. Compton, A. A., Hirsch, V. M. & Emerman, M. The host restriction factor APOBEC3G and retroviral Vif protein coevolve due to ongoing genetic conflict. Cell Host Microbe 11, 91-98 (2012).
44. Conticello, S. G., Thomas, C. J., Petersen-Mahrt, S. K. & Neuberger, M. S. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol. Biol. Evol. 22, 367-377 (2005).
45. OhAinle, M., Kerns, J. A., Malik, H. S. & Emerman, M. Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H. J. Virol. 80, 3853-3862 (2006).
46. LaRue, R. S. et al. The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multifunctional domain organization that existed in the ancestor of placental mammals. BMC Mol. Biol. 9, 104 (2008).
47. Münk, C. et al. Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol. 9, R48 (2008).
48. Bogerd, H. P., Tallmadge, R. L., Oaks, J. L., Carpenter, S. & Cullen, B. R. Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism. J. Virol. 82, 11889-11901 (2008).
49. Sawyer, S. L., Emerman, M. & Malik, H. S. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2, E275 (2004).
50. Duggal, N. K., Malik, H. S. & Emerman, M. The breadth of antiviral activity of Apobec3DE in chimpanzees has been driven by positive selection. J. Virol. 85, 11361-11371 (2011).
51. Staeheli, P. & Sutcliffe, J. G. Identification of a second interferon-regulated murine Mx gene. Mol. Cell. Biol. 8, 4524-4528 (1988).
52. Siegrist, F., Ebeling, M. & Certa, U. The small interferon-induced transmembrane genes and proteins. J. Interferon Cytokine Res. 31, 183-197 (2011).
53. Tareen, S. U., Sawyer, S. L., Malik, H. S. & Emerman, M. An expanded clade of rodent Trim5 genes. Virology 385, 473-483 (2009).
54. Sawyer, S. L., Emerman, M. & Malik, H. S. Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. PLoS Pathog. 3, e197 (2007).
55. Bishop, K. N. et al. Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr. Biol. 14, 1392-1396 (2004).
56. Simon, V. et al. Natural variation in Vif: differential impact on APOBEC3G/3F and a potential role in HIV-1 diversification. PLoS Pathog. 1, e6 (2005).
57. Tian, C. et al. Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F. J. Virol. 80, 3112-3115 (2006).
58. Russell, R. A. & Pathak, V. K. Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F. J. Virol. 81, 8201-8210 (2007).
59. Liao, C. H., Kuang, Y. Q., Liu, H. L., Zheng, Y. T. & Su, B. A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection. AIDS 21 (Suppl. 8), S19-S26 (2007).
60. Brennan, G., Kozyrev, Y. & Hu, S. L. TRIMCyp expression in Old World primates Macaca nemestrina and Macaca fascicularis. Proc. Natl Acad. Sci. USA 105, 3569-3574 (2008).
61. Newman, R. M. et al. Evolution of a TRIM5-CypA splice isoform in Old World monkeys. PLoS Pathog. 4, e1000003 (2008).
62. Virgen, C. A., Kratovac, Z., Bieniasz, P. D. & Hatziioannou, T. Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc. Natl Acad. Sci. USA 105, 3563-3568 (2008).
63. Wilson, S. J. et al. Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc. Natl Acad. Sci. USA 105, 3557-3562 (2008).
64. Sayah, D. M., Sokolskaja, E., Berthoux, L. & Luban, J. Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1. Nature 430, 569-573 (2004).
65. OhAinle, M., Kerns, J. A., Li, M. M., Malik, H. S. & Emerman, M. Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. Cell Host Microbe 4, 249-259 (2008).
66. Emerman, M. & Malik, H. S. Paleovirology - modern consequences of ancient viruses. PLoS Biol. 8, e1000301 (2010).
67. Katzourakis, A., Rambaut, A. & Pybus, O. G. The evolutionary dynamics of endogenous retroviruses. Trends Microbiol. 13, 463-468 (2005).
68. Gifford, R. J. et al. A transitional endogenous lentivirus from the genome of a basal primate and implications for lentivirus evolution. Proc. Natl Acad. Sci. USA 105, 20362-20367 (2008).
69. Gilbert, C., Maxfield, D. G., Goodman, S. M. & Feschotte, C. Parallel germline infiltration of a lentivirus in two Malagasy lemurs. PLoS Genet. 5, e1000425 (2009).
70. Katzourakis, A. & Gifford, R. J. Endogenous viral elements in animal genomes. PLoS Genet. 6, e1001191 (2010).
71. Pritchard, J. K., Pickrell, J. K. & Coop, G. The genetics of human adaptation: hard sweeps, soft sweeps, and polygenic adaptation. Curr. Biol. 20, R208-R215 (2010).
72. Sodora, D. L. et al. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nature Med. 15, 861-865 (2009).
73. Meiering, C. D. & Linial, M. L. Historical perspective of foamy virus epidemiology and infection. Clin. Microbiol. Rev. 14, 165-176 (2001).
74. Switzer, W. M. et al. Ancient co-speciation of simian foamy viruses and primates. Nature 434, 376-380 (2005).
75. Sharp, P. M. & Hahn, B. H. Origins of HIV and the AIDS pandemic. Cold Spring Harb. Perspect. Med. 1, a006841 (2011).
76. Kirmaier, A. et al. TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species. PLoS Biol. 8, e1000462 (2010).
77. Sauter, D. et al. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6, 409-421 (2009).
78. Sauter, D. et al. HIV-1 group P is unable to antagonize human tetherin by Vpu, Env or Nef. Retrovirology 8, 103 (2011).
79. Kirchhoff, F. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe 8, 55-67 (2010).
80. Albin, J. S. & Harris, R. S. Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert Rev. Mol. Med. 12, e4 (2010).
81. Lim, E. S. et al. The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 11, 194-204 (2012).
82. Laguette, N. et al. Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 11, 205-217 (2012).
83. Nathans, R. et al. Small-molecule inhibition of HIV-1 Vif. Nature Biotech. 26, 1187-1192 (2008).
84. Cen, S. et al. Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G. J. Biol. Chem. 285, 16546-16552 (2010).
85. Zhang, Q. et al. High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2. Antiviral Res. 91, 321-329 (2011).
86. Ganser-Pornillos, B. K. et al. Hexagonal assembly of a restricting TRIM5a protein. Proc. Natl Acad. Sci. USA 108, 534-539 (2011).
87. Matsuda, A. et al. Large-scale identification and characterization of human genes that activate NF-KB and MAPK signaling pathways. Oncogene 22, 3307-3318 (2003).
88. Lahouassa, H. et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nature Immunol. 13, 223-228 (2012).
89. Stetson, D. B., Ko, J. S., Heidmann, T. & Medzhitov, R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134, 587-598 (2008).
90. Nielsen, R. Molecular signatures of natural selection. Annu. Rev. Genet. 39, 197-218 (2005).
91. Nielsen, R., Hellmann, I., Hubisz, M., Bustamante, C. & Clark, A. G. Recent and ongoing selection in the human genome. Nature Rev. Genet. 8, 857-868 (2007).
92. Biswas, S. & Akey, J. M. Genomic insights into positive selection. Trends Genet. 22, 437-446 (2006).
93. Wolf, D. & Goff, S. P. Host restriction factors blocking retroviral replication. Annu. Rev. Genet. 42, 143-163 (2008).
94. Qi, C. F. et al. Molecular phylogeny of Fv1. Mamm. Genome 9, 1049-1055 (1998).
95. Sawyer, S., Wu, L, Emerman, M. & Malik, H. Positive selection of primate TRIM5a identifies a critical species-specific retroviral restriction domain. Proc. Natl Acad. Sci. USA 102, 2832-2837 (2005).
96. Kerns, J. A., Emerman, M. & Malik, H. S. Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. PLoS Genet. 4, e21 (2008).
97. Lim, E., Malik, H. & Emerman, M. Ancient adaptive evolution of Tetherin shaped Vpu and Nef functions in human immunodeficiency virus and primate lentiviruses. J. Virol. 84, 7124-7134 (2010).
98. McNatt, M. W. et al. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog. 5, e1000300 (2009).
99. Liu, S. Y., Sanchez, D. J. & Cheng, G. New developments in the induction and antiviral effectors of type I interferon. Curr. Opin. Immunol. 23, 57-64 (2011).
100. Lim, E. S., Wu, L. I., Malik, H. S. & Emerman, M. The function and evolution of the restriction factor viperin in primates was not driven by lentiviruses. Retrovirology 9, 55 (2012).
101. Sadler, A. J. & Williams, B. R. Interferon-inducible antiviral effectors. Nature Rev. Immunol. 8, 559-568 (2008).
102. Marshall, E. E., Bierle, C. J., Brune, W & Geballe, A. P. Essential role for either TRS1 or IRS1 in human cytomegalovirus replication. J. Virol. 83, 4112-4120 (2009).
103. Langland, J. O., Cameron, J. M., Heck, M. C, Jancovich, J. K. & Jacobs, B. L. Inhibition of PKR by RNA and DNA viruses. Virus Res. 119, 100-110 (2006).
104. Elde, N., Child, S., Geballe, A. & Malik, H. Protein kinase R reveals an evolutionary model for defeating viral mimicry. Nature 457, 485-489 (2009).